Source link : https://www.newshealth.biz/health-news/fda-approves-first-engineered-cell-therapy-for-a-solid-tumor/
The US Food and Drug Administration has approved afamitresgene autoleucel (afami-cel) (Tecelra, Adaptimmune LLC) to treat advanced synovial sarcoma. Afami-cel — the first engineered cell therapy for a solid tumor — is indicated specifically for adults with unresectable or metastatic synovial sarcoma who have received prior chemotherapy, are positive for several human leukocyte antigens (HLAs), […]
Author : News Health
Publish date : 2024-08-02 17:31:16
Copyright for syndicated content belongs to the linked Source.
Categories